98 related articles for article (PubMed ID: 24356563)
21. High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer.
Aparicio T; Schischmanoff O; Poupardin C; Mary F; Soufir N; Barrat C; Bellaiche G; Boubaya M; Choudat L; Cucherousset J; DesGuetz G; Wind P; Benamouzig R
J Geriatr Oncol; 2014 Oct; 5(4):384-8. PubMed ID: 25176643
[TBL] [Abstract][Full Text] [Related]
22. Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.
Harada T; Yamamoto E; Yamano HO; Aoki H; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Tanaka Y; Yoshida Y; Eizuka M; Yorozu A; Sudo G; Kitajima H; Niinuma T; Kai M; Sasaki Y; Tokino T; Sugai T; Nakase H; Suzuki H
J Gastroenterol; 2018 Dec; 53(12):1241-1252. PubMed ID: 29948303
[TBL] [Abstract][Full Text] [Related]
23. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.
Correa GT; Bernardes VF; de Sousa SF; Diniz MG; Salles JM; Souza RP; De-Paula AM; Gomez RS; Gomes CC
Tumour Biol; 2015 Nov; 36(11):9059-66. PubMed ID: 26084614
[TBL] [Abstract][Full Text] [Related]
24. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.
Rao B; Gao Y; Huang J; Gao X; Fu X; Huang M; Yao J; Wang J; Li W; Zhang J; Liu H; Wang L; Wang J
Int J Colorectal Dis; 2011 May; 26(5):593-601. PubMed ID: 21404058
[TBL] [Abstract][Full Text] [Related]
25. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
26. TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells.
Luu C; Heinrich EL; Duldulao M; Arrington AK; Fakih M; Garcia-Aguilar J; Kim J
PLoS One; 2013; 8(8):e70604. PubMed ID: 23936455
[TBL] [Abstract][Full Text] [Related]
27. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
[TBL] [Abstract][Full Text] [Related]
28. The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
Tanaka H; Beam MJ; Caruana K
Neoplasia; 2014 Oct; 16(10):814-23. PubMed ID: 25379018
[TBL] [Abstract][Full Text] [Related]
29. Three cases of rare salivary gland tumours: a molecular study of TP53, CDKN2A/ARF, RAS, BRAF, PTEN, MAPK2 and EGFR genes.
Falbo V; Floridia G; Censi F; Marra M; Foschini MP; Taruscio D
Oncol Rep; 2011 Jul; 26(1):3-11. PubMed ID: 21503581
[TBL] [Abstract][Full Text] [Related]
30. Interactions of multiple gene alterations in colorectal liver metastases.
Kawaguchi Y; Velasco JD; Arvide EM; Wei SH; Vauthey JN
Chin Clin Oncol; 2019 Oct; 8(5):50. PubMed ID: 31500427
[TBL] [Abstract][Full Text] [Related]
31. Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis.
Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
[No Abstract] [Full Text] [Related]
32. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia.
Aldiab A; Al Khayal KA; Al Obaid OA; Alsheikh A; Alsaleh K; Shahid M; Alkharji H
Oncology; 2017; 92(2):75-86. PubMed ID: 27915339
[TBL] [Abstract][Full Text] [Related]
34. Human germline and somatic cells have similar TP53 and Kirsten-RAS gene single base mutation frequencies.
Cole DN; Carlson JA; Wilson VL
Environ Mol Mutagen; 2008 Jul; 49(6):417-25. PubMed ID: 18418864
[TBL] [Abstract][Full Text] [Related]
35. Target Genetic Abnormalities for the Treatment of Colon Cancer and Its Progression to Metastasis.
Baviskar T; Momin M; Liu J; Guo B; Bhatt L
Curr Drug Targets; 2021; 22(7):722-733. PubMed ID: 33213339
[TBL] [Abstract][Full Text] [Related]
36. Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.
Iacopetta B; Russo A; Bazan V; Dardanoni G; Gebbia N; Soussi T; Kerr D; Elsaleh H; Soong R; Kandioler D; Janschek E; Kappel S; Lung M; Leung CS; Ko JM; Yuen S; Ho J; Leung SY; Crapez E; Duffour J; Ychou M; Leahy DT; O'Donoghue DP; Agnese V; Cascio S; Di Fede G; Chieco-Bianchi L; Bertorelle R; Belluco C; Giaretti W; Castagnola P; Ricevuto E; Ficorella C; Bosari S; Arizzi CD; Miyaki M; Onda M; Kampman E; Diergaarde B; Royds J; Lothe RA; Diep CB; Meling GI; Ostrowski J; Trzeciak L; Guzinska-Ustymowicz K; Zalewski B; Capellá GM; Moreno V; Peinado MA; Lönnroth C; Lundholm K; Sun XF; Jansson A; Bouzourene H; Hsieh LL; Tang R; Smith DR; Allen-Mersh TG; Khan ZA; Shorthouse AJ; Silverman ML; Kato S; Ishioka C;
Ann Oncol; 2006 May; 17(5):842-7. PubMed ID: 16524972
[TBL] [Abstract][Full Text] [Related]
37. The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations.
Chen J; Chang X; Li X; Liu J; Wang N; Wu Y; Zheng L; Nie X
Cancer Med; 2023 Dec; 12(24):21920-21932. PubMed ID: 38063316
[TBL] [Abstract][Full Text] [Related]
38. Mathematical modeling the order of driver gene mutations in colorectal cancer.
Li L; Hu Y; Xu Y; Tang S
PLoS Comput Biol; 2023 Jun; 19(6):e1011225. PubMed ID: 37368936
[TBL] [Abstract][Full Text] [Related]
39. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C
Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093
[TBL] [Abstract][Full Text] [Related]
40. Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Hasbullah HH; Musa M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]